130 related articles for article (PubMed ID: 9192431)
1. Value of low-dose gallium-67 imaging in detection of non-Hodgkin's lymphoma recurrence.
Nakayama M; Sakahara H; Minowa Y; Sasai K; Ishigaki T; Saga T; Nakamoto Y; Yao Z; Hiraoka M; Sakai K; Konishi J
Radiat Med; 1997; 15(2):79-83. PubMed ID: 9192431
[TBL] [Abstract][Full Text] [Related]
2. 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
Li S; Kurtaran A; Li M; Traub-Weidinger T; Kienast O; Schima W; Angelberger P; Virgolini I; Raderer M; Dudczak R
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1087-95. PubMed ID: 12768334
[TBL] [Abstract][Full Text] [Related]
3. Tl-201 and Ga-67 scintigraphy in non-Hodgkin's lymphoma.
Mansberg R; Wadhwa SS; Mansberg V
Clin Nucl Med; 1999 Apr; 24(4):239-42. PubMed ID: 10466518
[TBL] [Abstract][Full Text] [Related]
4. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
5. Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.
Ben-Haim S; Bar-Shalom R; Israel O; Haim N; Epelbaum R; Ben-Shachar M; Gaitini D; Kolodny GM; Front D
J Clin Oncol; 1996 Jun; 14(6):1936-42. PubMed ID: 8656263
[TBL] [Abstract][Full Text] [Related]
6. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
7. Lymphoma: predictive value of Ga-67 scintigraphy after treatment.
Front D; Ben-Haim S; Israel O; Epelbaum R; Haim N; Even-Sapir E; Kolodny GM; Robinson E
Radiology; 1992 Feb; 182(2):359-63. PubMed ID: 1732950
[TBL] [Abstract][Full Text] [Related]
8. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of (67)Ga scintigraphy in the diagnosis of lymphoma relapse].
Alvarez Ruiz S; Rodeño Ortiz De Zárate E; Alonso Colmenares I; Cortés Hernández J; Alcorta P
Rev Esp Med Nucl; 2002 Apr; 21(2):88-92. PubMed ID: 11879616
[TBL] [Abstract][Full Text] [Related]
10. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
Larcos G; Farlow DC; Antico VF; Gruenewald SM; Boyages J
Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ
J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
[TBL] [Abstract][Full Text] [Related]
12. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?
Chajari M; Lacroix J; Peny AM; Chesnay E; Batalla A; Henry-Amar M; Delcambre C; Génot JY; Fruchard C; Bardet S
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):380-7. PubMed ID: 12002715
[TBL] [Abstract][Full Text] [Related]
13. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
[TBL] [Abstract][Full Text] [Related]
14. Comparison of thallium-201 and gallium-67 scintigraphy in the evaluation of non-Hodgkin's lymphoma.
Roach PJ; Cooper RA; Arthur CK; Ravich RB
Aust N Z J Med; 1998 Feb; 28(1):33-8. PubMed ID: 9544384
[TBL] [Abstract][Full Text] [Related]
15. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
Nikpoor N; Aliabadi P; Diaz L; Mannting F
Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
[TBL] [Abstract][Full Text] [Related]
17. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
[TBL] [Abstract][Full Text] [Related]
18. [Value of scintigraphy with 99mTc-MIBI in the diagnosis and follow-up of Hodgkin's and non-Hodgkin's lymphomas].
Solano Bravo ME; Perera Pintado A; Gómez Pérez JR; Rodríguez Pérez JL; Sánchez Mendoza EL; Pérez Valdés M; Sánchez Del Campo Romero M
Rev Esp Med Nucl; 2000 Apr; 19(2):85-91. PubMed ID: 10799923
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of residual mediastinal tumor in patients with Hodgkin's lymphoma using computed tomography, magnetic resonance and 67Ga scintigraphy].
Capua A; Osti MF; Scattoni Padovan F; Sarra R; Sbarbati S; Anselmo AP; Maurizi Enrici R
Radiol Med; 1995 Dec; 90(6):797-803. PubMed ID: 8685466
[TBL] [Abstract][Full Text] [Related]
20. Visualization of esophageal non-Hodgkin's lymphoma with Ga-67 scintigraphy.
Nishryama Y; Yamamoto Y; Ono Y; Satoh K; Ohkawa M; Yamauchi A; Tanabe M
Ann Nucl Med; 1999 Dec; 13(6):419-21. PubMed ID: 10656277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
